Template:Stent thrombosis: Difference between revisions

	Coronary stent thrombosis Microchapters
Home
Introduction
Definition
Epidemiology and Demographics
Relation to Bare Metal Stents
Relation to Drug Eluting Stents
Sirolimus Eluting Stent vs Paclitaxel Eluting Stent
Relation to antiplatelet medications
Pathophysiology
Risk Factors for Coronary stent thrombosis
Relationship to Discontinuation of Antiplatelet Therapy
Treatment
Prognosis
Prevention
Stent thrombosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Stent thrombosis
CDC onStent thrombosis
Stent thrombosis in the news
Blogs on Stent thrombosis
to Hospitals Treating Stent thrombosis
Risk calculators and risk factors for Stent thrombosis

@@ Line 28: / Line 28: @@
 |- bgcolor="Pink"
 !
-Epidemiology & Demographics
+Epidemiology and Demographics
 |-
 !
@@ Line 46: / Line 46: @@
 |- bgcolor="Pink"
 !
-:[[Stent thrombosis incidence in drug eluting stents#Sirolimus eluting stent(SES) vs paclitaxel eluting stent(PES)|Sirolimus eluting stent vs Paclitaxel eluting stent]]
+:[[Stent thrombosis incidence in drug eluting stents#Sirolimus eluting stent(SES) vs paclitaxel eluting stent(PES)|Sirolimus Eluting Stent vs Paclitaxel Eluting Stent]]
 |-
 !
@@ Line 70: / Line 70: @@
 |- bgcolor="Pink"
 !
-[[Stent thrombosis relationship to discontinuation of antiplatelet therapy|Premature discontinuation of antiplatelet therapy]]
+[[Stent thrombosis relationship to discontinuation of antiplatelet therapy|Relationship to Discontinuation of Antiplatelet Therapy]]
 |-
 !

Revision as of 15:36, 5 March 2013